These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 215180)

  • 21. Serological aspects of rat tumour xenograft growth in athymic nude mice.
    Pimm MV; Baldwin RW
    Br J Cancer; 1979 Feb; 39(2):116-21. PubMed ID: 373782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
    Sato M; Nomoto K; Yano Y; Taniguchi K; Takeya K
    Gan; 1976 Dec; 67(6):835-47. PubMed ID: 1088135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individually distinct tumor-specific cell surface antigen identified by monoclonal antibody on a Rous sarcoma virus-induced mouse tumor.
    Kuzumaki N; Minakawa H; Miyazaki T; Haraguchi S; Matsuo T; Yoshida TO
    J Natl Cancer Inst; 1982 Aug; 69(2):527-30. PubMed ID: 6287079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of tumor-specific transplantation antigens of MC-29 chicken hepatoma and Rous sarcoma virus-induced sarcomas in mice.
    Elek G; Lapis K; Földes I
    J Toxicol Environ Health; 1979; 5(2-3):529-36. PubMed ID: 224208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rous sarcoma virus-induced tumours in mice. II. Contribution of H-2 and non-H-2 alloantigen barriers to tumour immunogenicity in vivo.
    Forni G; Giovarelli M; Sarzotti M; Whitmore AC
    J Immunogenet; 1983 Jun; 10(3):209-20. PubMed ID: 6308100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
    Skornick Y; Kurman CC; Sindelar WF
    Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.
    Wolf A; Steele KA; Alexander P
    Br J Cancer; 1976 Feb; 33(2):144-53. PubMed ID: 1259913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor rejection antigens of chemically induced sarcomas of inbred mice.
    Srivastava PK; DeLeo AB; Old LJ
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3407-11. PubMed ID: 3458189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
    Hewitt HB; Blake ER; Walder AS
    Br J Cancer; 1976 Mar; 33(3):241-59. PubMed ID: 773395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour cell destruction by macrophages from conventional animals.
    Holán V; Hasek M; Bubeník J
    Folia Biol (Praha); 1975; 21(1):43-9. PubMed ID: 164392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of tumors induced in adult Macaca mulata monkeys with Carr-Zilber strain of Rous sarcoma virus.
    Adgighitov FI; Gubeladze DA; Lapin BA; Hlozánek I; Sovová V; Cerná H
    Neoplasma; 1980; 27(2):159-64. PubMed ID: 6248800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
    Forni G; Comoglio PM
    Br J Cancer; 1974 Oct; 30(4):365-9. PubMed ID: 4447779
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
    Bubeník J; Indrová M; Malkovský M; Símová J
    Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of cyclophosphamide-treated tumor cells.
    Kawalec M; Skórski T; Hoser G
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):345-50. PubMed ID: 3250356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.